Evaluation of XRCC1 Gene Polymorphism as a Biomarker in Head and Neck Cancer Patients Undergoing Chemoradiation Therapy
- 1 July 2018
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 101 (3) , 593-601
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- XRCC1 codon 399Gln polymorphism is associated with radiotherapy-induced acute dermatitis and mucositis in nasopharyngeal carcinoma patientsRadiation Oncology, 2013
- Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3 randomised trialThe Lancet Oncology, 2012
- Association Between Genetic Polymorphisms in the XRCC1, XRCC3, XPD, GSTM1, GSTT1, MSH2, MLH1, MSH3, and MGMT Genes and Radiosensitivity in Breast Cancer PatientsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- Association between single nucleotide polymorphisms in the XRCC1 and RAD51 genes and clinical radiosensitivity in head and neck cancerRadiotherapy and Oncology, 2011
- Polymorphisms in DNA damage response genes and head and neck cancer riskBiomarkers, 2010
- Genetic polymorphisms in DNA base excision repair gene XRCC1 and the risk of squamous cell carcinoma of the head and neckJournal of Experimental & Clinical Cancer Research, 2009
- Séquelles radio-induites et tests prédictifsCancer/Radiothérapie, 2008
- Combinational polymorphisms of four DNA repair genes XRCC1, XRCC2, XRCC3, and XRCC4 and their association with oral cancer in TaiwanJournal of Oral Pathology & Medicine, 2007
- In vitro radiation‐induced expression of XPC mRNA as a possible biomarker for developing adverse reactions during radiotherapyInternational Journal of Cancer, 2007
- Cisplatin and Radiotherapy in the Treatment of Locally Advanced Head and Neck CancerActa Oncologica, 2003